Vore M, Hadd H, Slikker W
Life Sci. 1983 Jun 27;32(26):2989-93. doi: 10.1016/0024-3205(83)90650-1.
17 alpha-Ethynylestradiol-17 beta (beta-D-glucuronide) [EE217 beta (beta G)], a metabolite of 17 alpha-ethynylestradiol (EE2) identified in urine of women taking EE2 in oral contraceptives, and its synthetic anomer, 17 alpha-ethynylestradiol-17 beta (alpha-D-glucuronide), [EE217 beta (alpha G)], were administered intravenously to female rats in order to determine their effects on bile flow. Both agents induced an immediate, profound and dose-dependent decrease in bile flow which returned to control levels within 1-8 hr. The logarithm of the dose vs the cholestatic response curves for the two anomers were not parallel. EE217 beta (alpha G) was significantly more potent than EE217 beta (beta G) such that the doses inhibiting bile flow by 50% were 1.25 and 11 mumol/kg for the alpha-and beta-anomer respectively.
17α-乙炔雌二醇-17β(β-D-葡萄糖醛酸苷)[EE217β(βG)]是在服用口服避孕药的女性尿液中发现的17α-乙炔雌二醇(EE2)的一种代谢产物,以及其合成端基异构体17α-乙炔雌二醇-17β(α-D-葡萄糖醛酸苷)[EE217β(αG)],通过静脉注射给予雌性大鼠,以确定它们对胆汁流量的影响。两种药物均引起胆汁流量立即、显著且剂量依赖性的降低,并在1-8小时内恢复到对照水平。两种端基异构体的剂量对数与胆汁淤积反应曲线不平行。EE217β(αG)的效力明显高于EE217β(βG),使得抑制胆汁流量50%的α-和β-端基异构体剂量分别为1.25和11μmol/kg。